Choosing Wisely in endometrial & cervix cancers: Medical therapy

Mirvetuximab soravtansine and pembrolizumab combo shows promise in endometrial cancer subtype

The treatment of cervical cancer in the presence of HIV in Sub-Saharan Africa

Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours

First-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for R/M cervical cancer

Atezolizumab with platinum-based CT and niraparib show no improvement in survival for rOC

Induction chemotherapy added to chemoradiation improves PFS and OS in advanced cervical cancer

OncoAlert round up July 28th to August 3rd, 2023

Gynaecological cancer: New targets and immunotherapy developments